Skip to main content

Table 1 Trial structure

From: Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial

Cycle

1

2

3

4

5

6

Cluster 1

+suPAR

Control

+suPAR

Control

+suPAR

Control

Cluster 2

Control

+suPAR

Control

+suPAR

Control

+suPAR

  1. Each cycle consists of three weeks with or without suPAR measurements in the ED
  2. ED emergency department, SuPAR soluble urokinase plasminogen activator receptor